Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Joseph

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Circulation|April 28, 2021
Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 CountriesIsabelle Johansson, Philip Joseph, Kumar Balasubramanian, et al.
European Heart Journal|June 22, 2022
Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudySidong Li, Zhiguang Liu, Philip Joseph, et al.
Lancet (London, England)|September 8, 2019
Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort studyGilles R Dagenais, Darryl P Leong, Sumathy Rangarajan, et al.
Lancet (London, England)|May 24, 2020
Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort studyMarjan Walli-Attaei, Philip Joseph, Annika Rosengren, et al.
Journal of the American College of Cardiology|April 22, 2026
Heart Failure Among 173,000 Community-Dwelling Participants From 25 Low-, Middle-, and High-Income Countries in the PURE StudyIsabelle Johansson Bartolini, Philip Joseph, Shofiqul Islam, et al.
Lancet (London, England)|September 8, 2019
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort studySalim Yusuf, Philip Joseph, Sumathy Rangarajan, et al.
The Lancet. Global Health|April 28, 2019
Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) studyAnnika Rosengren, Andrew Smyth, Sumathy Rangarajan, et al.
JAMA|May 16, 2023
Global Variations in Heart Failure Etiology, Management, and Outcomes, Philip Joseph, Ambuj Roy, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Circulation|April 28, 2021
Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 CountriesIsabelle Johansson, Philip Joseph, Kumar Balasubramanian, et al.
European Heart Journal|June 22, 2022
Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudySidong Li, Zhiguang Liu, Philip Joseph, et al.
Lancet (London, England)|September 8, 2019
Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort studyGilles R Dagenais, Darryl P Leong, Sumathy Rangarajan, et al.
Lancet (London, England)|May 24, 2020
Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort studyMarjan Walli-Attaei, Philip Joseph, Annika Rosengren, et al.
Journal of the American College of Cardiology|April 22, 2026
Heart Failure Among 173,000 Community-Dwelling Participants From 25 Low-, Middle-, and High-Income Countries in the PURE StudyIsabelle Johansson Bartolini, Philip Joseph, Shofiqul Islam, et al.
Lancet (London, England)|September 8, 2019
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort studySalim Yusuf, Philip Joseph, Sumathy Rangarajan, et al.
The Lancet. Global Health|April 28, 2019
Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) studyAnnika Rosengren, Andrew Smyth, Sumathy Rangarajan, et al.
JAMA|May 16, 2023
Global Variations in Heart Failure Etiology, Management, and Outcomes, Philip Joseph, Ambuj Roy, et al.
Pageof 11